Mark J. Kwakkenbos

2.1k total citations
22 papers, 1.4k citations indexed

About

Mark J. Kwakkenbos is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mark J. Kwakkenbos has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Mark J. Kwakkenbos's work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Mark J. Kwakkenbos is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Mark J. Kwakkenbos collaborates with scholars based in Netherlands, United Kingdom and United States. Mark J. Kwakkenbos's co-authors include Jörg Hamann, Siamon Gordon, Martin Stacey, Hsi‐Hsien Lin, Hergen Spits, Tim Beaumont, Gin-Wen Chang, Etsuko Yasuda, Sean A. Diehl and Ferenc A. Scheeren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Mark J. Kwakkenbos

22 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J. Kwakkenbos Netherlands 18 661 568 259 234 225 22 1.4k
Anne Marie‐Cardine France 30 660 1.0× 1.4k 2.5× 129 0.5× 432 1.8× 267 1.2× 71 2.3k
Osamu Hosono Japan 23 491 0.7× 352 0.6× 110 0.4× 623 2.7× 106 0.5× 70 1.4k
G J Freeman United States 21 443 0.7× 1.9k 3.4× 197 0.8× 485 2.1× 125 0.6× 25 2.6k
Susanne Edelhoff United States 20 866 1.3× 893 1.6× 167 0.6× 203 0.9× 102 0.5× 35 1.9k
Dominique Piatier‐Tonneau France 20 429 0.6× 571 1.0× 190 0.7× 406 1.7× 82 0.4× 36 1.3k
Shigeaki Ohno Japan 18 366 0.6× 484 0.9× 91 0.4× 199 0.9× 210 0.9× 39 1.5k
Andrew Sprague United States 13 421 0.6× 745 1.3× 122 0.5× 209 0.9× 108 0.5× 17 1.4k
Georg Tiefenthaler Germany 18 400 0.6× 983 1.7× 404 1.6× 225 1.0× 97 0.4× 29 1.6k
Christophe C. Marchal United States 17 652 1.0× 700 1.2× 79 0.3× 196 0.8× 164 0.7× 24 1.6k
David B. Durand United States 8 1.2k 1.8× 829 1.5× 111 0.4× 351 1.5× 83 0.4× 11 1.8k

Countries citing papers authored by Mark J. Kwakkenbos

Since Specialization
Citations

This map shows the geographic impact of Mark J. Kwakkenbos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Kwakkenbos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Kwakkenbos more than expected).

Fields of papers citing papers by Mark J. Kwakkenbos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Kwakkenbos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Kwakkenbos. The network helps show where Mark J. Kwakkenbos may publish in the future.

Co-authorship network of co-authors of Mark J. Kwakkenbos

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Kwakkenbos. A scholar is included among the top collaborators of Mark J. Kwakkenbos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Kwakkenbos. Mark J. Kwakkenbos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldeck, David, P. Roychoudhury, Katy Moffat, et al.. (2019). Establishment of Systems to Enable Isolation of Porcine Monoclonal Antibodies Broadly Neutralizing the Porcine Reproductive and Respiratory Syndrome Virus. Frontiers in Immunology. 10. 572–572. 6 indexed citations
2.
Germar, Kristine, Cynthia M. Fehres, Hans Ulrich Scherer, et al.. (2018). Generation and Characterization of Anti–Citrullinated Protein Antibody–Producing B Cell Clones From Rheumatoid Arthritis Patients. Arthritis & Rheumatology. 71(3). 340–350. 21 indexed citations
3.
Slot, Linda M., Thera A.M. Wormhoudt, Mark J. Kwakkenbos, et al.. (2018). De novo gene mutations in normal human memory B cells. Leukemia. 33(5). 1219–1230. 4 indexed citations
4.
Gram, Anna M., et al.. (2017). Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposure. Molecular Immunology. 91. 225–237. 33 indexed citations
5.
Donkers, Joanne M., Gerard J. P. van Westen, Mark J. Kwakkenbos, et al.. (2017). Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP. Scientific Reports. 7(1). 15307–15307. 73 indexed citations
6.
Kwakkenbos, Mark J., Pauline M. van Helden, Tim Beaumont, & Hergen Spits. (2016). Stable long‐term cultures of self‐renewing B cells and their applications. Immunological Reviews. 270(1). 65–77. 33 indexed citations
7.
Wagner, Koen, Mark J. Kwakkenbos, Martino Böhne, et al.. (2014). Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity. Proceedings of the National Academy of Sciences. 111(47). 16820–16825. 67 indexed citations
8.
Kwakkenbos, Mark J., Arjen Q. Bakker, Pauline M. van Helden, et al.. (2013). Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire. Methods. 65(1). 38–43. 17 indexed citations
9.
Kwakkenbos, Mark J., Sean A. Diehl, Etsuko Yasuda, et al.. (2009). Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming. Nature Medicine. 16(1). 123–128. 220 indexed citations
10.
11.
Diehl, Sean A., Heike Schmidlin, Maho Nagasawa, et al.. (2008). STAT3-Mediated Up-Regulation of BLIMP1 Is Coordinated with BCL6 Down-Regulation to Control Human Plasma Cell Differentiation. The Journal of Immunology. 180(7). 4805–4815. 178 indexed citations
12.
Hamann, Jörg, Nathalie Koning, Walter Pouwels, et al.. (2007). EMR1, the human homolog of F4/80, is an eosinophil‐specific receptor. European Journal of Immunology. 37(10). 2797–2802. 108 indexed citations
13.
MacLeod, Megan K. L., Mark J. Kwakkenbos, Alison Crawford, et al.. (2006). CD4 memory T cells survive and proliferate but fail to differentiate in the absence of CD40. The Journal of Experimental Medicine. 203(4). 897–906. 40 indexed citations
14.
Kwakkenbos, Mark J., Gwendoline J.D. Teske, Maarten C. Kraan, et al.. (2005). Identification of the epidermal growth factor–TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue. Arthritis & Rheumatism. 52(2). 442–450. 45 indexed citations
15.
Kwakkenbos, Mark J., Walter Pouwels, Mourad Matmati, et al.. (2004). Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells. Journal of Leukocyte Biology. 77(1). 112–119. 72 indexed citations
16.
Gordon, Siamon, Hsi‐Hsien Lin, Jörg Hamann, et al.. (2004). The EGF-TM7 family: a postgenomic view. Immunogenetics. 55(10). 655–666. 105 indexed citations
17.
Chang, Gin-Wen, Martin Stacey, Mark J. Kwakkenbos, et al.. (2003). Proteolytic cleavage of the EMR2 receptor requires both the extracellular stalk and the GPS motif. FEBS Letters. 547(1-3). 145–150. 56 indexed citations
18.
Hamann, Jörg, et al.. (2003). Inactivation of the EGF‐TM7 receptor EMR4 after the Pan‐Homo divergence. European Journal of Immunology. 33(5). 1365–1371. 36 indexed citations
19.
Stacey, Martin, Gin-Wen Chang, John Q. Davies, et al.. (2003). The epidermal growth factor–like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans. Blood. 102(8). 2916–2924. 177 indexed citations
20.
Kwakkenbos, Mark J., Gin-Wen Chang, Hsi‐Hsien Lin, et al.. (2002). The human EGF-TM7 family member EMR2 is a heterodimeric receptor expressed on myeloid cells. Journal of Leukocyte Biology. 71(5). 854–862. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Marie‐Cardine Breakdown of academic impact, for papers by Osamu Hosono Breakdown of academic impact, for papers by G J Freeman Breakdown of academic impact, for papers by Susanne Edelhoff Breakdown of academic impact, for papers by Dominique Piatier‐Tonneau Breakdown of academic impact, for papers by Shigeaki Ohno Breakdown of academic impact, for papers by Andrew Sprague Breakdown of academic impact, for papers by Georg Tiefenthaler Breakdown of academic impact, for papers by Christophe C. Marchal Breakdown of academic impact, for papers by David B. Durand
Rankless by CCL
2026